NSC |
Compound |
Enrichment |
Correlation |
NSC 656210 |
Null |
0.0174989034030623 |
0.4168681 |
NSC 658828 |
Null |
0.0174989034030623 |
0.35276275 |
NSC 673141 |
Null |
0.0174989034030623 |
0.37825896 |
NSC 683086 |
Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- |
0.0174989034030623 |
0.33768409 |
NSC 689735 |
Null |
0.0174989034030623 |
0.43231421 |
NSC 699757 |
Null |
0.0174989034030623 |
0.41446993 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0174989034030623 |
0.2485709 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0174989034030623 |
0.31549891 |
NSC 728316 |
6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride |
0.0174989034030623 |
0.03405102 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.0174989034030623 |
0.41708961 |